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UNIT A17.1MRI of the Adrenal Glands
MRI is an effective method to evaluate adrenal pathology. The authors employ a set
protocol incorporating various types of T1- and T2-weighted sequences including the use
of in-phase and out-of-phase gradient echo techniques and the routine use of intravenous
gadolinium.
BASIC
PROTOCOL
ADRENAL IMAGING
The high signal-to-noise ratio (SNR) obtained at high field strength makes it possible to
image the adrenal glands during a single breath-hold sequence. The sequences described
herein are based on the authors’ experience with a Siemens 1.5 T Vision scanner, but are
expected to be equally applicable to machines from other manufacturers.
Scanning a patient or volunteer is a joint effort among technologists, nurses, and
physicians, with the technologist normally responsible for following proper scanning
protocols and techniques. Unless otherwise specified, in what follows, the person to whom
directions are given is assumed to be the technologist. Table A17.1.1 lists the hardware
necessary to perform the procedure, along with appropriate parameters.
The following ten sequences comprise the adrenal imaging protocol. This protocol
employs multiple data acquisitions and serial post-gadolinium imaging. Most sequences
require the patient to be able to suspend respiration for ∼25 sec. It is imperative that there
be clear communication between the technologist and the patient throughout the exam.
This protocol results in consistent, reproducible image quality that is effective for
evaluating the full spectrum of adrenal diseases.
NOTE: Be sure that technologists and nurses have immediate access to any emergency
equipment that may be relevant to a given study, or that may be needed for a particular
patient, such as crash carts or oxygen.
Materials
Normal saline (0.9% NaCl), sterile, 40 ml minimum
Extravascular contrast agent (e.g., Magnevist, Omniscan, or Prohance), volume is
prescribed by patient weight
Set up patient and equipment
1. Interview the patient to assess for contraindications such as cardiac pacemakers,
implanted mechanical devices, and/or ferromagnetic materials. Also, determine if the
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Table A17.1.1 Equipment Specifications Needed to Perform the Following
Imaging Sequences
Coil type Circular polarized body phased array coil
Manufacturer and system type Siemens, Vision
Field strength 1.5 T
Gradient strength 24 mT/m (or whatever the system permits, but
minimum of 24 mT/m for sequences 2 and 4)
Knee cushion Yes
Use of contrast agents Yes
Pulse oximeter If patient requires sedation
Power injector Yes
Normal saline Yes
35" extension tubing Yes
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patient will need sedation medication necessitating the use of appropriate monitoring
equipment.
A screening form is signed by each patient or legal guardian prior to bringing the patient
into the exam area.
The presence of ferromagnetic materials may be a health hazard to the patient while in the
magnetic field and/or adversely affect image quality. To determine the safety of scanning
such ferromagnetic materials see Shellock and Kanal (1996).
The presence of ferromagnetic materials in the globe of the eye is contraindicated for MRI.
Patients with prior metal exposure to the eye should have plain X rays of the orbital area
to ensure that all metal has been removed prior to placing them in the magnetic field.
2. Request that the patient change into a gown and remove all personal effects such as
jewelry, hearing aids, and glasses, prior to entering the MRI scan room. All personal
belongings should be secured during the examination.
3. Explain the procedure to the patient and record relevant clinical history. Ensure that
the patient understands what is expected, ask if the patient has any questions, and
answer appropriately.
4. Fill a 20-ml syringe with normal saline and attach to a 35-in. saline-filled extension
tubing. Obtain i.v. access utilizing a 22-G angiocatheter and attach the saline-pre-
pared extension tubing and syringe. This allows flushing of the extension tubing while
the patient waits to be imaged. In cases where a power injector is not available, this
allows for preparation for bolus injection (see note below). Secure the position of
angiocatheter with tegraderm or tape.
Obtaining i.v. access prior to entering the scan room will promote patient throughput and
eliminate “dead” time of starting the i.v. while the patient is on the exam table. Follow
power injector manufacturer guidelines with regard to appropriate-gauge needle/angio-
catheter to be used; this will depend on chosen injection/flow rates.
NOTE: If access to a power injector is not available, performing dynamic imaging is still
possible as the extension tubing will allow the saline syringe to be placed at the foot of the
patient table during pre-contrast imaging. In this case, the contrast agent will need to be
drawn up by another syringe. When the bolus injection of the contrast agent is prepared,
simply disconnect the saline syringe and connect the syringe filled with the contrast agent;
once the bolus of contrast agent is injected, reconnect the saline syringe and bolus an
appropriate volume of flush, usually ∼10 ml. Alternatively, to eliminate the need of
switching syringes, incorporate the use of a 3-way stopcock.
5. Set up the exam room by securing the circularly polarized (CP)-body array coil onto
the table and providing a clean exam table.
6. Set up the power injector as specified by the manufacturer. A minimum of 40 ml
normal saline should be drawn-up to ensure sufficient saline is available to keep the
vein open (KVO) throughout the exam. To determine the amount of contrast agent to
be used, reference the contrast packet insert and draw-up the amount indicated per
kilogram of patient weight. There is no need to double dose.
7. Escort the patient to the MR examination room and ask them to lie down accordingly
with respect to the exam to be performed. Connect the extension tubing secured to
the syringe to the power injector extension tubing. Review the following items with
the patient:
a. Provide earplugs or headphones to the patient to minimize the loud knocking noise
that will be produced by the gradients, but ensure them that the patient will still
be able to hear you.
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b. Provide the patient with a safety squeeze-bulb and demonstrate how it works;
explain to the patient when to use the squeeze-bulb (i.e., if assistance is needed
during the exam).
c. Explain to the patient that you will be talking to them between imaging sequences
which will be when the loud knocking noise stops. Additionally, review breath
holding instructions with the patient.
d. Explain to the patient that it is imperative to remain motionless during the loud
knocking noise to ensure good results; also explain that one should not reposition
one’s body between imaging sequences.
e. Position a support under the patient’s knees to enhance patient comfort.
f. Provide the patient with an approximate time that the examination will take.
8. Secure the top portion of the CP–body array coil to prevent it from moving side-to-
side during breath-holding imaging sequences.
Usually there are straps provided by the manufacturer that are directly attached to the coil.
9. Use the laser light to position the patient and to center the coil (see Table A17.1.2).
10. Advance the patient table to isocenter.
11. Program the power injector for a contrast agent and saline injection rate of 2 ml/sec.
Total volume of saline following contrast agent injection should be programmed for
10 ml. Program a scan delay of 18 sec (contrast agent is injected, scan is initiated 18
sec after contrast agent and saline are delivered). Arm the power injector and keep
the vein open. Do not inject the contrast agent.
Sequence 1: Three-plane positioning scout
12. To validate the patient’s position and to have a reference to prescribe successive
imaging sequences, acquire a three-plane orthogonal scout sequence using parame-
ters in Table A17.1.2.
Most MR scanners can be programmed to acquire the scout automatically after coil tuning
or after the patient has been placed in isocenter (for systems that do not require tuning).
Sequence 2: Half-acquisition (partial Fourier) turbo spin echo (HASTE) coronal
13. Display both the coronal and transverse scout images in two separate quadrants on
the scan monitor. Change imaging parameters to those listed in Table A17.1.3.
Position slices to center of the transverse scout ensuring that the adrenals are covered.
14. Instruct the patient to remain motionless and to breathe normally as the scan will
begin and last for ∼40 sec.
Sequence 3: Gradient echo coronal
15. Change imaging parameters to those listed in Table A17.1.4. Position slices to center
of the transverse scout ensuring that the adrenals are covered.
16. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it. Run the scan.
Sequence 4: Half-acquisition turbo spin echo transverse with fat saturation (fat
suppression)
17. Display both the coronal and transverse scout images in two separate quadrants on
the scan monitor (see step 13). Change imaging parameters to those listed in Table
A17.1.5. Position slices to cover from the diaphragm to the aortic bifurcation.
18. Perform system shim as recommended by manufacturer, as this is a fat saturation
sequence.
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Table A17.1.3 Imaging Parameters for Sequence 2 (Half-Acquisition Turbo
Spin Echo)
Patient position Supine
Scan type Half-acquisition turbo spin echo
Imaging plane (orientation) Coronal
Central slice or volume center Slices posted on transverse scout;
center to adrenals
Echo time (TE) 90 msec
Repeat time (TR) 4.4 mseca
Delay time 1500 msec
Flip angle (FA) 150°
Field of view (FOVx, FOVy) 400 mm, 400 mm
Resolution (∆x, ∆y) 1.56 mm, 2.08 mm
Number of data points collected (Nx, Ny) 256, 192 (using half Fourier)
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8–10 mm
Number of slices 20
Slice gap 1.6–2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice locations Centered to adrenals
Saturation pulses No
Slice series Interleaved
Scan time 40 sec
aThe true TR is infinite; 4.4 msec represents the echo spacing.
Table A17.1.2 Imaging Parameters for Sequence 1 (Scout Sequence)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Sagittal, transverse, and coronal
Central slice or volume center Laser light centered
approximately one hand width
above the inferior rib margin
Echo time (TE) 6 msec
Repeat time (TR) 15 msec
Flip angle (FA) 30°
Field of view (FOVx, FOVy) 450 mm, 450 mm
Resolution (∆x, ∆y) 1.76 mm, 3.52 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 10 mm
Number of slices 3
Slice gap Not applicable
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice locations Not applicable
Saturation pulses Not applicable
Scan time 16 sec
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Table A17.1.4 Imaging Parameters for Sequence 3 (Gradient Echo)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Coronal
Central slice or volume center Slices posted on transverse scout;
center to adrenals
Echo time (TE) 4.1 msec
Repetition time (TR) 140 msec
Flip angle (FA) 80°
Field of view (FOVx, FOVy) 400 mm, 400 mm
Resolution (∆x, ∆y) 1.56 mm, 3.13 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8–10 mm
Number of slices 20
Slice gap 1.6–2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice locations Centered to cover adrenals
Saturation pulses No
Slice series Interleaved
Scan time 18 sec
Table A17.1.5 Imaging Parameters for Sequence 4 (Half-Acquisition Turbo
Spin Echo with Fat Saturation)
Patient position Supine
Scan type Half-acquisition turbo spin echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
adrenals
Echo time (TE) 90 msec
Repeat time (TR) 4.4 mseca
Delay time 1500 msec
Flip angle (FA) 150°
Field of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 1.37 mm
Number of data points collected (Nx, Ny) 256, 192 (using half Fourier)
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8–10 mm
Number of slices 20
Slice gap 1.6–2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice locations Centered to cover adrenals
Saturation pulses Yes, superior and inferior to slices
Fat suppression Yes
Slice series Interleaved
Scan time 40 sec
aThe true TR is infinite; 4.4 msec represents the echo spacing.
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19. Instruct the patient to remain motionless and to breathe normally as the scan will
begin and last for ∼40 sec.
Sequence 5: Transverse gradient echo with fat saturation (Figure A17.1.1)
20. Display the coronal images (use breath-hold images from sequence 3) on the scan
monitor. Change imaging parameters to those listed in Table A17.1.6. Position slices
to center of the coronal gradient echo image ensuring that the adrenals are covered.
Figure A17.1.1 Unenhanced fat suppressed transverse spoiled gradient echo
image.
Table A17.1.6 Imaging Parameters for Sequence 5 (Gradient Echo with Fat
Saturation)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
adrenals
Echo time (TE) 4.1 msec
Repeat time (TR) 147.2 msec
Flip angle (FA) 80°
Field of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 2.05 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 6 mm
Number of slices 20
Slice gap 1.2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice locations Centered to cover adrenals
Saturation pulses No
Fat suppression Yes
Slice series Interleaved
Scan time 19 sec
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It is imperative that the slices are prescribed off of the breath-hold gradient echo images
from sequence 3 as this is a breath-held imaging sequence. Otherwise, the slice location
will not be accurate relative to the reference image if a nonbreath-held image is used.
21. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it. Run the scan.
Sequence 6: Transverse gradient echo (out-of-phase) (Figure A17.1.2)
22. Display the midline slice of the gradient echo coronal image (sequence 3) and the
previous transverse gradient echo image in two separate quadrants on the scan
Figure A17.1.2 Out-of-phase transverse spoiled gradient echo image.
Table A17.1.7 Imaging Parameters for Sequence 6 (Gradient
Echo–Out-of-Phase)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to
adrenals
Echo time (TE) 2.2 msec
Repeat time (TR) 140 msec
Flip angle (FA) 80°
Field of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 2.05 mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8–10 mm
Number of slices 20
Slice gap 1.6–2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice locations Centered to adrenals
Saturation pulses No
Slice series Interleaved
Scan time 19 sec
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monitor. Change imaging parameters to those listed in Table A17.1.7. Position slices
to cover the adrenals.
It is imperative that the slices are prescribed off of the gradient echo coronal image as this
is a breath-held imaging sequence. Otherwise, the slice location will not be accurate
relative to the reference image if a non-breath-held image is used.
23. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it. Run the scan.
Sequence 7: Transverse gradient echo
24. Display the midline slice of the gradient echo coronal image (sequence 3) and the
previous transverse gradient echo image in two separate quadrants on the scan
monitor. Change imaging parameters to those listed in Table A17.1.8. Position slices
to cover the adrenals.
It is imperative that the slices are prescribed off of the gradient echo coronal image as this
is a breath-held imaging sequence. Otherwise, the slice location will not be accurate
relative to the reference image if a non-breath-held image is used.
25. Instruct the patient to take in a deep breath and exhale, take in another deep breath
and hold it. Run the scan.
Sequence 8: Transverse gradient echo—immediate post contrast (Figure A17.1.3)
See patient set up section for specific instructions on preparation for contrast agent
injection. This preparation must be done prior to placing the patient in the scanner.
26. Repeat step 24.
It is imperative that the slices be prescribed off of the gradient echo coronal image as this
is a breath-held imaging sequence. Otherwise, the slice location will not be accurate
relative to the reference image if a non-breath-held image is used.
27. Explain to the patient that you will now be injecting the contrast agent and he/she
may feel a cool sensation in his/her arm. Initiate the injection. Do not begin scanning
Table A17.1.8 Imaging Parameters for Sequence 7 (Gradient Echo)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to adrenals
Echo time (TE) 4.5 msec
Repeat time (TR) 140 msec
Flip angle (FA) 80°
Field of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 2.05mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8–10 mm
Number of slices 18
Slice gap 1.6–2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice locations Centered to cover adrenals
Saturation pulses No
Slice series Interleaved
Scan time 18 sec
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until the 18 sec scan delay has expired. However, breathing instructions should be
delivered when 10 sec of delay are remaining (see step 28).
If you do not have access to a power injector and are “hand” injecting, you can still use
step 27. However, after you have completed the bolus contrast agent injection, reattach the
saline-filled syringe and flush with 10 ml of saline. Begin breathing instructions after 5 ml
of the saline has been injected then proceed to initiate the scan. The process of switching
syringes must be completed as quickly as possible and thus, the suggestion of incorporating
the use of a 3-way stopcock.
28. When there are 10 sec of delay remaining, instruct the patient to take in a deep breath
and exhale, take in another deep breath and hold it. Run the scan.
Sequence 9: Transverse gradient echo—45 sec delay after injection (Figure A17.1.4)
29. Repeat step 24.
Figure A17.1.4 One-minute post gadolinium spoiled gradient echo transverse
image.
Figure A17.1.3 Immediate post contrast transverse spoiled gradient echo
image.
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It is imperative that the slices are prescribed off of the gradient echo coronal image as this
is a breath-held imaging sequence. Otherwise, the slice location will not be accurate
relative to the reference image if a non-breath-held image is used.
30. Once 45 sec has expired, instruct the patient to take in a deep breath and exhale, take
in another deep breath and hold it. Run the scan.
Figure A17.1.5 Post-contrast fat suppressed transverse spoiled gradient echo
image.
Table A17.1.9 Imaging Parameters for Sequence 10 (Gradient Echo with Fat
Saturation, 90 Sec Delay)
Patient position Supine
Scan type Gradient echo
Imaging plane (orientation) Transverse
Central slice or volume center Slices posted on coronal; center to adrenals
Echo time (TE) 4.1 msec
Repeat time (TR) 147.2 msec
Flip angle (FA) 80°
Field of view (FOVx, FOVy) 350 mm, 263 mm
Resolution (∆x, ∆y) 1.37 mm, 2.05mm
Number of data points collected (Nx, Ny) 256, 128
Display matrix (Dx, Dy) 256, 256
Slice thickness (∆z) 8–10 mm
Number of slices 20
Slice gap 1.6–2 mm
Number of acquisitions (Nacq) 1
Swap read and phase encoding No
Slice locations Centered to cover adrenals
Saturation pulses No
Fat suppression Yes
Slice series Interleaved
Scan time 19 sec
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Sequence 10: Transverse gradient echo with fat saturation (90 sec delay after
injection) (Figure A17.1.5)
31. Display the midline slice of the gradient echo coronal image (sequence 3) and the
previous transverse gradient echo image in two separate quadrants on the scan
monitor using parameters in Table A17.1.9. Position slices to cover the adrenals.
It is imperative that the slices are prescribed off of the gradient echo coronal image as this
is a breath-held imaging sequence. Otherwise, the slice location will not be accurate
relative to the reference image if a non-breath-held image is used.
32. Once 90 sec has expired, instruct the patient to take in a deep breath and exhale, take
in another deep breath and hold it. Run the scan.
COMMENTARY
Background Information
The most common indication for MR of the
adrenals is to distinguish adenoma from metas-
tases (Mitchell et al., 1992; Tsushima et al.,
1993; Lee et al., 1994; Reinig et al., 1994;
Bilbey et al., 1995; Korobkin et al., 1995, 1996;
Mayo-Smith et al., 1995; McNicholas et al.,
1995; Outwater et al., 1995, 1996). The above
described protocol employs gadolinium con-
trast in order that the full range of adrenal
diseases may be evaluated. The use of gadolin-
ium is not, however, essential if the clinical
question is just the characterization of a known
adrenal mass such as adenoma or metastasis.
The next most common indication is the detec-
tion of pheochromocytoma (Lee et al., 1994).
Rather than having separate protocols for ade-
noma versus metastases and pheochromocy-
toma search, we combine both indications into
a single protocol to maintain study simplicity.
Critical Parameters and
Troubleshooting
The most critical sequences are in-phase and
out-of-phase spoiled gradient echo (Mitchell et
al., 1992; Tsushima et al., 1993; Lee et al.,
1994; Reinig et al., 1994; Bilbey et al., 1995;
Korobkin et al., 1995; Mayo-Smith et al., 1995;
McNicholas et al., 1995; Outwater et al., 1995).
It is essential that patients be able to hold their
breath in order to achieve optimal results. In the
event that patients are unable to breath-hold,
contrast computed tomography (CT) should be
performed. Results with Hounsfield unit meas-
urements on non-contrast CT and observed loss
of signal from in-phase to out-of-phase MRI
are comparable for the characterization of ad-
renal masses as adenomas (Korobkin et al.,
1996; Outwater et al., 1996).
In looking for pheochromocytomas, the fat
suppressed T2-weighted HASTE sequence is
the sequence (sequence 4) in the protocol that
is employed for this detection. Pheochromocy-
tomas are moderately high in signal on the fat
suppressed T2-weighted HASTE and are gen-
erally higher in signal than other adrenal
masses and higher in signal than the majority
of retroperitoneal structures. As fat suppressed
T2-weighted HASTE is breathing independent,
there is no requirement that the patient be able
to suspend respiration in order to search for
pheochromocytomas.
Anticipated Results
In patients who are able to suspend respira-
tion for 20 sec, successful imaging of the full
range of adrenal abnormalities is achieved. This
single protocol is designed to image the various
types of disease processes that affect the adre-
nal glands. The combination of in-phase and
out-of-phase images distinguish between be-
nign adenomas and metastases.
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